Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/BASILEA-PHARMACEUTICA-AG-130199/news/GNW-Basilea-gibt-Zulassung-von-Antibiotikum-Zevtera-in-China-zur-Behandlung-31704895/?utm_source=whatsapp&utm_medium=social&utm_campaign=share